Lazard Capital Starts Alexion Pharmaceuticals (ALXN) at Neutral
Tweet Send to a FriendGet Alerts ALXN Hot Sheet
Price: $102.90 +1.06%
Rating Summary:
10 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
10 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade ALXN Now!
Lazard Capital initiates coverage on Alexion Pharmaceuticals (NASDAQ: ALXN) with a Neutral.
For an analyst ratings summary and ratings history on Alexion Pharmaceuticals click here. For more ratings news on Alexion Pharmaceuticals click here.
Shares of Alexion Pharmaceuticals closed at $106.13 yesterday, with a 52 week range of $46.56-$109.96.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Alexion Pharmaceuticals click here. For more ratings news on Alexion Pharmaceuticals click here.
Shares of Alexion Pharmaceuticals closed at $106.13 yesterday, with a 52 week range of $46.56-$109.96.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
- Barclays Starts Crown Castle (CCI) at Equalweight
- Credit Suisse Starts New Residential Investment (NRZ) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Lazard
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
